Literature DB >> 24294824

Multilayered polymer-coated carbon nanotubes to deliver dasatinib.

Thomas L Moore1, Stuart W Grimes, Robert L Lewis, Frank Alexis.   

Abstract

Multilayered, multifunctional polymer coatings were grafted onto carbon nanotubes (CNTs) using a one-pot, ring-opening polymerization in order to control the release kinetic and therapeutic efficacy of dasatinib. Biocompatible, biodegradable multilayered coatings composed of poly(glycolide) (PGA) and poly(lactide) (PLA) were polymerized directly onto hydroxyl-functionalized CNT surfaces. Sequential addition of monomers into the reaction vessel enabled multilayered coatings of PLA-PGA or PGA-PLA. Poly(ethylene glycol) capped the polymer chain ends, resulting in a multifunctional amphiphilic coating. Multilayer polymer coatings on CNTs enabled control of the anticancer drug dasatinib's release kinetics and enhanced the in vitro therapeutic efficacy against U-87 glioblastoma compared to monolayer polymer coatings.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24294824      PMCID: PMC4065492          DOI: 10.1021/mp400448w

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  31 in total

1.  Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays.

Authors:  Louis J Lombardo; Francis Y Lee; Ping Chen; Derek Norris; Joel C Barrish; Kamelia Behnia; Stephen Castaneda; Lyndon A M Cornelius; Jagabandhu Das; Arthur M Doweyko; Craig Fairchild; John T Hunt; Ivan Inigo; Kathy Johnston; Amrita Kamath; David Kan; Herbert Klei; Punit Marathe; Suhong Pang; Russell Peterson; Sidney Pitt; Gary L Schieven; Robert J Schmidt; John Tokarski; Mei-Li Wen; John Wityak; Robert M Borzilleri
Journal:  J Med Chem       Date:  2004-12-30       Impact factor: 7.446

2.  Deep-tissue anatomical imaging of mice using carbon nanotube fluorophores in the second near-infrared window.

Authors:  Kevin Welsher; Sarah P Sherlock; Hongjie Dai
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-16       Impact factor: 11.205

3.  Designing multilayered particulate systems for tunable drug release profiles.

Authors:  Wei Li Lee; Pattara-orn Yu; Meiju Hong; Effendi Widjaja; Say Chye Joachim Loo
Journal:  Acta Biomater       Date:  2012-02-13       Impact factor: 8.947

4.  Altering the drug release profiles of double-layered ternary-phase microparticles.

Authors:  Wei Li Lee; Cedric Loei; Effendi Widjaja; Say Chye Joachim Loo
Journal:  J Control Release       Date:  2011-02-23       Impact factor: 9.776

5.  Small-molecule release from poly(D,L-lactide)/poly(D,L-lactide-co-glycolide) composite microparticles.

Authors:  Emily J Pollauf; Kyekyoon Kevin Kim; Daniel W Pack
Journal:  J Pharm Sci       Date:  2005-09       Impact factor: 3.534

6.  Incorporation and controlled release of silyl ether prodrugs from PRINT nanoparticles.

Authors:  Matthew C Parrott; Mathew Finniss; J Chris Luft; Ashish Pandya; Anuradha Gullapalli; Mary E Napier; Joseph M DeSimone
Journal:  J Am Chem Soc       Date:  2012-04-30       Impact factor: 15.419

7.  Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.

Authors:  Jeffrey Hrkach; Daniel Von Hoff; Mir Mukkaram Ali; Elizaveta Andrianova; Jason Auer; Tarikh Campbell; David De Witt; Michael Figa; Maria Figueiredo; Allen Horhota; Susan Low; Kevin McDonnell; Erick Peeke; Beadle Retnarajan; Abhimanyu Sabnis; Edward Schnipper; Jeffrey J Song; Young Ho Song; Jason Summa; Douglas Tompsett; Greg Troiano; Tina Van Geen Hoven; Jim Wright; Patricia LoRusso; Philip W Kantoff; Neil H Bander; Christopher Sweeney; Omid C Farokhzad; Robert Langer; Stephen Zale
Journal:  Sci Transl Med       Date:  2012-04-04       Impact factor: 17.956

8.  Tissue histology and physiology following intravenous administration of different types of functionalized multiwalled carbon nanotubes.

Authors:  Lara Lacerda; Hanene Ali-Boucetta; Maria A Herrero; Giorgia Pastorin; Alberto Bianco; Maurizio Prato; Kostas Kostarelos
Journal:  Nanomedicine (Lond)       Date:  2008-04       Impact factor: 5.307

9.  Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study.

Authors:  Craig A Poland; Rodger Duffin; Ian Kinloch; Andrew Maynard; William A H Wallace; Anthony Seaton; Vicki Stone; Simon Brown; William Macnee; Ken Donaldson
Journal:  Nat Nanotechnol       Date:  2008-05-20       Impact factor: 39.213

10.  Fluorine-labeled dasatinib nanoformulations as targeted molecular imaging probes in a PDGFB-driven murine glioblastoma model.

Authors:  Miriam Benezra; Dolores Hambardzumyan; Oula Penate-Medina; Darren R Veach; Nagavarakishore Pillarsetty; Peter Smith-Jones; Evan Phillips; Tatsuya Ozawa; Pat B Zanzonico; Valerie Longo; Eric C Holland; Steven M Larson; Michelle S Bradbury
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

View more
  7 in total

1.  Development and Characterization of the Paclitaxel loaded Riboflavin and Thiamine Conjugated Carbon Nanotubes for Cancer Treatment.

Authors:  Swati Singh; Neelesh Kumar Mehra; N K Jain
Journal:  Pharm Res       Date:  2016-04-18       Impact factor: 4.200

Review 2.  Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and Uses.

Authors:  Panoraia I Siafaka; Neslihan Üstündağ Okur; Evangelos Karavas; Dimitrios N Bikiaris
Journal:  Int J Mol Sci       Date:  2016-08-31       Impact factor: 5.923

Review 3.  Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma.

Authors:  Amy Lee Bredlau; Suraj Dixit; Chao Chen; Ann-Marie Broome
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

4.  Poly(Cyclohexene Phthalate) Nanoparticles for Controlled Dasatinib Delivery in Breast Cancer Therapy.

Authors:  Enrique Niza; Cristina Nieto-Jiménez; María Del Mar Noblejas-López; Iván Bravo; José Antonio Castro-Osma; Felipe de la Cruz-Martínez; Marc Martínez de Sarasa Buchaca; Inmaculada Posadas; Jesús Canales-Vázquez; Agustín Lara-Sanchez; Daniel Hermida-Merino; Eduardo Solano; Alberto Ocaña; Carlos Alonso-Moreno
Journal:  Nanomaterials (Basel)       Date:  2019-08-27       Impact factor: 5.076

5.  Nanoparticles as Carriers of Proteins, Peptides and Other Therapeutic Molecules.

Authors:  Agnieszka Pudlarz; Janusz Szemraj
Journal:  Open Life Sci       Date:  2018-10-31       Impact factor: 0.938

Review 6.  Nanoscale Drug Delivery Systems in Glioblastoma.

Authors:  Zihao Liu; Xiaoshuai Ji; Dong He; Rui Zhang; Qian Liu; Tao Xin
Journal:  Nanoscale Res Lett       Date:  2022-02-16       Impact factor: 5.418

Review 7.  Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?

Authors:  Daniel Ruiz-Molina; Xiaoman Mao; Paula Alfonso-Triguero; Julia Lorenzo; Jordi Bruna; Victor J Yuste; Ana Paula Candiota; Fernando Novio
Journal:  Cancers (Basel)       Date:  2022-10-10       Impact factor: 6.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.